JP2010517955A5 - - Google Patents

Download PDF

Info

Publication number
JP2010517955A5
JP2010517955A5 JP2009547651A JP2009547651A JP2010517955A5 JP 2010517955 A5 JP2010517955 A5 JP 2010517955A5 JP 2009547651 A JP2009547651 A JP 2009547651A JP 2009547651 A JP2009547651 A JP 2009547651A JP 2010517955 A5 JP2010517955 A5 JP 2010517955A5
Authority
JP
Japan
Prior art keywords
ono
formula
group
linear
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009547651A
Other languages
English (en)
Japanese (ja)
Other versions
JP5216782B2 (ja
JP2010517955A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/050938 external-priority patent/WO2008095806A1/en
Publication of JP2010517955A publication Critical patent/JP2010517955A/ja
Publication of JP2010517955A5 publication Critical patent/JP2010517955A5/ja
Application granted granted Critical
Publication of JP5216782B2 publication Critical patent/JP5216782B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009547651A 2007-02-05 2008-01-28 酸化窒素放出性ステロイド Expired - Fee Related JP5216782B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US89937607P 2007-02-05 2007-02-05
US60/899,376 2007-02-05
US92945607P 2007-06-28 2007-06-28
US60/929,456 2007-06-28
PCT/EP2008/050938 WO2008095806A1 (en) 2007-02-05 2008-01-28 Nitric oxide releasing steroids

Publications (3)

Publication Number Publication Date
JP2010517955A JP2010517955A (ja) 2010-05-27
JP2010517955A5 true JP2010517955A5 (enExample) 2011-03-17
JP5216782B2 JP5216782B2 (ja) 2013-06-19

Family

ID=39232800

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009547651A Expired - Fee Related JP5216782B2 (ja) 2007-02-05 2008-01-28 酸化窒素放出性ステロイド

Country Status (15)

Country Link
US (4) US20100041633A1 (enExample)
EP (3) EP2109618A1 (enExample)
JP (1) JP5216782B2 (enExample)
KR (1) KR20090107525A (enExample)
CN (1) CN101652380A (enExample)
AU (1) AU2008213046B2 (enExample)
BR (1) BRPI0807078A2 (enExample)
CA (3) CA2677290A1 (enExample)
ES (1) ES2601102T3 (enExample)
IL (1) IL199815A (enExample)
MX (1) MX2009008334A (enExample)
NZ (1) NZ579067A (enExample)
RU (1) RU2442790C2 (enExample)
WO (3) WO2008095808A1 (enExample)
ZA (1) ZA200905067B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2560634A1 (en) 2010-04-23 2013-02-27 Piramal Enterprises Limited Nitric oxide releasing prodrugs of therapeutic agents
US8846723B2 (en) 2010-07-29 2014-09-30 Eastman Chemical Company Esters of O-substituted hydroxy carboxylic acids and preparations thereof
WO2013053856A1 (en) 2011-10-12 2013-04-18 Ascendis Pharma A/S Prevention and treatment of ocular conditions
MX390974B (es) * 2011-12-20 2025-03-13 Oriflame Cosmetics Ag Uso cosmético o dermatológico de naringenina para combatir efectos de envejecimiento de la piel.
US10980860B2 (en) 2012-10-11 2021-04-20 Ascendis Pharma A/S Diagnosis, prevention and treatment of diseases of the joint
US9844599B2 (en) 2013-01-21 2017-12-19 Apparao Satyam Nitric oxide releasing produgs of therapeutic agents
RU2545416C1 (ru) * 2014-02-18 2015-03-27 Ксения Юрьевна Еременко Способ лечения возрастной макулярной дистрофии
CN103880907A (zh) * 2014-03-11 2014-06-25 天津金耀集团有限公司 丁酸氢化可的松半水合物
KR102835535B1 (ko) 2016-11-08 2025-07-18 리제너론 파마슈티칼스 인코포레이티드 스테로이드 및 이의 단백질-접합체
CN110944718A (zh) 2017-05-18 2020-03-31 里珍纳龙药品有限公司 环糊精蛋白质药物偶联物
AU2018365946B2 (en) 2017-11-07 2025-08-28 Regeneron Pharmaceuticals, Inc. Hydrophilic linkers for antibody drug conjugates
MX2020006994A (es) 2018-01-08 2020-11-06 Regeneron Pharma Esteroides y conjugados de anticuerpos de los mismos.
CN118955710A (zh) 2018-05-09 2024-11-15 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
MX2021002380A (es) * 2018-08-31 2021-07-15 Aerie Pharmaceuticals Inc Conjugados de isoquinolina-esteroide y usos de los mismos.
WO2022135332A1 (zh) * 2020-12-21 2022-06-30 映恩生物制药(苏州)有限公司 一种甾体偶联物
JP7687973B2 (ja) * 2022-01-24 2025-06-03 芳弘 二村 フィブロネクチン活性化作用を介した表皮細胞増殖作用を呈するジテルペン誘導体

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3183252A (en) 1963-09-05 1965-05-11 Syntex Corp 16-nitratoalkyl-pregnanes
US3494941A (en) 1967-12-04 1970-02-10 American Home Prod Nitrate esters of 17beta-(hydroxyalkoxy)steroid 3-ols,3-ones and 3-amidinohydrazones
HU164115B (enExample) 1971-05-07 1973-12-28
IT1285770B1 (it) * 1996-10-04 1998-06-18 Nicox Sa Composti corticoidei
IT1311922B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
ITMI20020148A1 (it) * 2002-01-29 2003-07-29 Nicox Sa Nuovi corticosteroidi
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
SG158916A1 (en) 2005-09-02 2010-02-26 Nicox Sa Nitrooxy derivatives op glucocorticoids

Similar Documents

Publication Publication Date Title
JP2010517955A5 (enExample)
CN100469765C (zh) 前列腺素硝基氧衍生物
JP2022081661A5 (enExample)
JP2009504763A5 (enExample)
JP2020063241A5 (enExample)
RU2008143668A (ru) Производное инсулина
JP2006515838A5 (enExample)
RU2011103741A (ru) Композиции и способы лечения заболевания сетчатки
RU2010116708A (ru) Бициклическое производное гамма-аминокислоты
JP2007510662A5 (enExample)
ES2437346T3 (es) Procedimiento para la producción de derivado de diamina
WO2019131580A1 (ja) カチオン性脂質
JP2006507220A5 (enExample)
JP2004517098A5 (enExample)
JP2011519360A5 (enExample)
JP2006504738A5 (enExample)
CN104039765A (zh) 多奈哌齐双羟萘酸盐、制备方法及其应用
RU2374228C2 (ru) Производные 4-фенилпиперидина в качестве ингибиторов ренина
JP2020511450A5 (enExample)
JP2005526138A5 (enExample)
JP2009525970A5 (enExample)
JP2005514440A5 (enExample)
JP5341521B2 (ja) タンパク質と結合パートナーとの相互作用を阻害するための化合物及び方法
JP2008542386A5 (enExample)
CA2589744A1 (en) Pyrrolinidium derivatives as m3 muscarinic receptors